Peer-influenced content. Sources you trust. No registration required. This is HCN.
ACP Internist
Dive into this intriguing case of a young woman presenting with right calf pain and an acute thrombosis. Join your peers in discerning the most appropriate therapeutic strategy, deepening your clinical acumen in the process.
Hematology July 12th 2023
ACP Hospitalist
The new recommendations include continuing antiplatelet therapy for patients with a baseline indication for it, starting dual antiplatelet therapy for patients with confirmed ACS, and adding prophylactic-dose LMWH for patients on antiplatelet therapy for a previous stroke.
Cardiology July 12th 2023
NEJM Evidence
Reconsideration of routine thromboprophylaxis in older adults may be warranted, as the SYMPTOMS trial found no significant difference in the prevention of symptomatic venous thromboembolism when comparing low-molecular-weight heparin with a placebo. Further research is needed to validate these results and determine the best strategies for VTE prevention in this demographic.
Cardiology July 3rd 2023
The New England Journal of Medicine
Evaluating the Timing of DOAC Initiation Post-Stroke: Key Findings Here are the key findings from a recent multi-country, open-label research that explores the best time to start direct oral anticoagulants (DOACs) in atrial fibrillation patients after a stroke.
Cardiology June 6th 2023
Guideline Central
Check out the updated guideline for changes prevention and treatment of VTE in a variety of cancer settings.
Family Medicine/General Practice May 3rd 2023
ReachMD
Because each patient reports unique challenges, there is no “one size fits all” approach to managing cancer-associated venous thrombosis (CAT). Thrombosis is a complication that HCPs are not recognizing early enough in the face of multiple options for appropriately treating and managing CAT; additionally, there is a lack of awareness of new CAT management clinical data. Although the morbidity and mortality of VTE in cancer patients remain high, unfortunately, its management is not given the same priority. And although recommendations suggest an individualized approach to managing these patients, clinical practice adoption is slow. Published guidelines and clinical trial data do not always correspond to real-world practice and prescribing practices. As a result, many existing CAT management protocols must be updated as new guidance is warranted.
Oncology, Medical April 3rd 2023